Dermatitis, Atopic

"Dermatitis, Atopic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.

Descriptor ID	D003876
MeSH Number(s)	C16.320.850.210 C17.800.174.193 C17.800.815.193 C17.800.827.210 C20.543.480.343
Concept/Terms	Dermatitis, Atopic Dermatitis, Atopic Atopic Dermatitides Atopic Dermatitis Dermatitides, Atopic Neurodermatitis, Atopic Atopic Neurodermatitides Atopic Neurodermatitis Neurodermatitides, Atopic Neurodermatitis, Disseminated Disseminated Neurodermatitides Disseminated Neurodermatitis Neurodermatitides, Disseminated Eczema, Atopic Atopic Eczema Eczema, Infantile Eczema, Infantile Infantile Eczema

Below are MeSH descriptors whose meaning is more general than "Dermatitis, Atopic".

Diseases [C]
Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
Genetic Diseases, Inborn [C16.320]
Skin Diseases, Genetic [C16.320.850]
Dermatitis, Atopic [C16.320.850.210]
Skin and Connective Tissue Diseases [C17]
Skin Diseases [C17.800]
Dermatitis [C17.800.174]
Dermatitis, Atopic [C17.800.174.193]
Skin Diseases, Eczematous [C17.800.815]
Dermatitis, Atopic [C17.800.815.193]
Skin Diseases, Genetic [C17.800.827]
Dermatitis, Atopic [C17.800.827.210]
Immune System Diseases [C20]
Hypersensitivity [C20.543]
Hypersensitivity, Immediate [C20.543.480]
Dermatitis, Atopic [C20.543.480.343]

Below are MeSH descriptors whose meaning is related to "Dermatitis, Atopic".

Below are MeSH descriptors whose meaning is more specific than "Dermatitis, Atopic".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Dermatitis, Atopic" by people in this website by year, and whether "Dermatitis, Atopic" was a major or minor topic of these publications.

Bar chart showing 33 publications over 18 distinct years, with a maximum of 5 publications in 2018

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	2	0	2
2005	1	0	1
2006	0	2	2
2007	1	1	2
2008	3	1	4
2009	1	0	1
2010	2	0	2
2011	1	0	1
2012	1	0	1
2013	1	0	1
2014	1	0	1
2015	1	0	1
2017	1	0	1
2018	4	1	5
2019	2	1	3
2021	1	0	1
2022	2	0	2
2023	2	0	2

Below are the most recent publications written about "Dermatitis, Atopic" by people in Profiles.

Ung CY, Warwick A, Onoufriadis A, Barker JN, Parsons M, McGrath JA, Shaw TJ, Dand N. Comorbidities of Keloid and Hypertrophic Scars Among Participants in UK Biobank. JAMA Dermatol. 2023 Feb 01; 159(2):172-181.

View in: PubMed
Ahn K, Penn RB, Rattan S, Panettieri RA, Voight BF, An SS. Mendelian Randomization Analysis Reveals a Complex Genetic Interplay among Atopic Dermatitis, Asthma, and Gastroesophageal Reflux Disease. Am J Respir Crit Care Med. 2023 01 15; 207(2):130-137.

View in: PubMed
Bielory L. Immunobiologicals and ocular surface disease. Curr Opin Allergy Clin Immunol. 2022 10 01; 22(5):314-318.

View in: PubMed
Chen J, Bielory L. Atopic keratoconjunctivitis alleviated with dupilumab. Ann Allergy Asthma Immunol. 2022 09; 129(3):375-376.

View in: PubMed
Valentine L, Norris MR, Bielory L. Comparison of structural components and functional mechanisms within the skin vs. the conjunctival surface. Curr Opin Allergy Clin Immunol. 2021 10 01; 21(5):472-479.

View in: PubMed
Igelman S, Kurta AO, Sheikh U, McWilliams A, Armbrecht E, Jackson Cullison SR, Kress DW, Smith A, Castelo-Soccio L, Treat J, Boothe WD, Diaz LZ, Levy ML, Patel A, Lee LW, Fraile-Alonso MC, Antaya RJ, Shah S, Kittler N, Arkin L, Siegfried E. Off-label use of dupilumab for pediatric patients with atopic dermatitis: A multicenter retrospective review. J Am Acad Dermatol. 2020 Feb; 82(2):407-411.

View in: PubMed
Nichols RG, Peters JM, Patterson AD. Interplay Between the Host, the Human Microbiome, and Drug Metabolism. Hum Genomics. 2019 06 11; 13(1):27.

View in: PubMed
Elias MS, Wright SC, Remenyi J, Abbott JC, Bray SE, Cole C, Edwards S, Gierlinski M, Glok M, McGrath JA, Nicholson WV, Paternoster L, Prescott AR, Have ST, Whitfield PD, Lamond AI, Brown SJ. EMSY expression affects multiple components of the skin barrier with relevance to atopic dermatitis. J Allergy Clin Immunol. 2019 08; 144(2):470-481.

View in: PubMed
Paller A, Jaworski JC, Simpson EL, Boguniewicz M, Russell JJ, Block JK, Tofte S, Dunn JD, Feldman SR, Clark AR, Schwartz G, Eichenfield LF. Major Comorbidities of Atopic Dermatitis: Beyond Allergic Disorders. Am J Clin Dermatol. 2018 Dec; 19(6):821-838.

View in: PubMed
Guttman-Yassky E, Bissonnette R, Ungar B, Su?rez-Fari?as M, Ardeleanu M, Esaki H, Suprun M, Estrada Y, Xu H, Peng X, Silverberg JI, Menter A, Krueger JG, Zhang R, Chaudhry U, Swanson B, Graham NMH, Pirozzi G, Yancopoulos GD, D Hamilton JD. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis. J Allergy Clin Immunol. 2019 01; 143(1):155-172.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement